Novel leukocyte-depleted platelet-rich plasma-based skin equivalent as an in vitro model of chronic wounds: a preliminary study

BMC Molecular and Cell Biology - 2021
Elisa Seria1, George Galea2, Joseph Borg3, Kevin Schembri4, Godfrey Grech4, Sarah Samut Tagliaferro1, Alex E. Felice1
1Department of Physiology and Biochemistry and Centre of Molecular Medicine and Biobanking, Faculty of Medicine and Surgery, University of Malta, Msida, MSD2080, Malta
2National Blood Transfusion Centre and Department of Pathology, University of Malta, Msida, MSD2080, Malta
3Department of Applied Biomedical Science, Faculty of Health Sciences, University of Malta, Msida, MSD2080, Malta
4Department of Surgery, Faculty of Medicine and Surgery, University of Malta Medical School and Mater Dei Hospital, Msida, MSD2080, Malta

Tóm tắt

Abstract Background Chronic leg ulcerations are associated with Haemoglobin disorders, Type2 Diabetes Mellitus, and long-term venous insufficiency, where poor perfusion and altered metabolism develop into a chronic inflammation that impairs wound closure. Skin equivalent organotypic cultures can be engineered in vitro to study skin biology and wound closure by modelling the specific cellular components of the skin. This study aimed to develop a novel bioactive platelet-rich plasma (PRP) leukocyte depleted scaffold to facilitate the study of common clinical skin wounds in patients with poor chronic skin perfusion and low leukocyte infiltration. A scratch assay was performed on the skin model to mimic two skin wound conditions, an untreated condition and a condition treated with recombinant tumour necrotic factor (rTNF) to imitate the stimulation of an inflammatory state. Gene expression of IL8 and TGFA was analysed in both conditions. Statistical analysis was done through ANOVA and paired student t-test. P < 0.05 was considered significant. Results A skin model that consisted of a leukocyte-depleted, platelet-rich plasma scaffold was setup with embedded fibroblasts as dermal equivalents and seeded keratinocytes as multi-layered epidermis. Gene expression levels of IL8 and TGFA were significantly different between the control and scratched conditions (p < 0.001 and p < 0.01 respectively), as well as between the control and treated conditions (p < 0.01 and p < 0.001 respectively). The scratch assay induced IL8 upregulation after 3 h (p < 0.05) which continued to increase up to day 1 (p < 0.05). On the other hand, the administration of TNF led to the downregulation of IL8 (p < 0.01), followed by an upregulation on day 2. IL8 gene expression decreased in the scratched condition after day 1 as the natural healing process took place and was lower than in the treated condition on day 8 (p < 0.05). Both untreated and treated conditions showed a downregulation of TGFA 3 h after scratch when compared with the control condition (p < 0.01). Administration of rTNF showed significant downregulation of TGFA after 24 h when compared with the control (p < 0.01) and treated conditions (p < 0.05). Conclusion This study suggests that a leukocyte-depleted PRP-based skin equivalent can be a useful model for the in vitro study of chronic skin wounds related to poor skin perfusion.

Từ khóa


Tài liệu tham khảo

Ruckley CV. Socioeconomic impact of chronic venous insufficiency and leg ulcers. Angiology. 1997;48(1):67–9. https://doi.org/10.1177/000331979704800111.

Scerri CA, Abela W, Galdies R, Pizzuto M, Grech JL, Felice AE. The beta + IVS, I-NT no. 6 (T --> C) thalassaemia in heterozygotes with an associated Hb Valletta or Hb S heterozygosity in homozygotes from Malta. Br J Haematol. 1993;83(4):669–71. https://doi.org/10.1111/j.1365-2141.1993.tb04710.x.

Minniti CP, Eckman J, Sebastiani P, Steinberg MH, Ballas SK. Leg ulcers in sickle cell disease. Am J Hematol. 2010;85(10):831–3. https://doi.org/10.1002/ajh.21838.

Minniti CP, Delaney KM, Gorbach AM, Xu D, Lee CC, Malik N, et al. Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia. Am J Hematol. 2014;89(1):1–6. https://doi.org/10.1002/ajh.23571.

Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J. Body iron metabolism and pathophysiology of iron overload. Int J Hematol. 2008;88(1):7–15. https://doi.org/10.1007/s12185-008-0120-5.

Sen CK. Wound healing essentials: let there be oxygen. Wound Repair Regen. 2009;17(1):1–18. https://doi.org/10.1111/j.1524-475X.2008.00436.x.

Schreml S, Szeimies RM, Prantl L, Karrer S, Landthaler M, Babilas P. Oxygen in acute and chronic wound healing. Br J Dermatol. 2010;163(2):257–68. https://doi.org/10.1111/j.1365-2133.2010.09804.x.

Bell E, Ehrlich HP, Sher S, Merrill C, Sarber R, Hull B, et al. Development and use of a living skin equivalent. Plast Reconstr Surg. 1981;67(3):386–92. https://doi.org/10.1097/00006534-198103000-00024.

El Ghalbzouri A, Ponec M. Diffusible factors released by fibroblasts support epidermal morphogenesis and deposition of basement membrane components. Wound Repair Regen. 2004;12(3):359–67. https://doi.org/10.1111/j.1067-1927.2004.012306.x.

Kubo K, Kuroyanagi Y. A study of cytokines released from fibroblasts in cultured dermal substitute. Artif Organs. 2005;29(10):845–9. https://doi.org/10.1111/j.1525-1594.2005.00138.x.

Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, et al. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci. 2004;30(2):145–51. https://doi.org/10.1016/j.transci.2004.01.004.

Pankov R, Yamada KM. Fibronectin at a glance. J Cell Sci. 2002;115(20):3861–3. https://doi.org/10.1242/jcs.00059.

Dovi JV, He LK, DiPietro LA. Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol. 2003;73(4):448–55. https://doi.org/10.1189/jlb.0802406.

Anitua E, Zalduendo M, Troya M, Padilla S, Orive G. Leukocyte inclusion within a platelet rich plasma-derived fibrin scaffold stimulates a more pro-inflammatory environment and alters fibrin properties. PLoS One. 2015;10(3):e0121713. https://doi.org/10.1371/journal.pone.0121713.

Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992;10(1):411–52. https://doi.org/10.1146/annurev.iy.10.040192.002211.

Baggiolini M, Loetscher P, Moser B. Interleukin-8 and the chemokine family. Int J Immunopharmacol. 1995;17(2):103–8. https://doi.org/10.1016/0192-0561(94)00088-6.

Ellis S, Lin EJ, Tartar D. Immunology of wound healing. Curr Dermatol Rep. 2018;7(4):350–8. https://doi.org/10.1007/s13671-018-0234-9.

Hsu YC, Pasolli HA, Fuchs E. Dynamics between stem cells, niche, and progeny in the hair follicle. Cell. 2011;144(1):92–105. https://doi.org/10.1016/j.cell.2010.11.049.

Poblet E, Jimenez F, Godinez JM, et al. The immunohistochemical expression of CD34 in human hair follicles: a comparative study with the bulge marker CK15. Clin Exp Dermatol. 2006;31(6):807–12. https://doi.org/10.1111/j.1365-2230.2006.02255.x.

Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB, et al. Characterization and isolation of stem cellenriched human hair follicle bulge cells. J Clin Invest. 2006;116(1):249–60. https://doi.org/10.1172/JCI26043.

Sidney LE, Branch MJ, Dunphy SE, Dua HS, Hopkinson A. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells. 2014;32(6):1380–9. https://doi.org/10.1002/stem.1661.

Corbeil D, Fargeas CA, Jaszai J. CD133 might be a pan marker of epithelial cells with dedifferentiation capacity. Proc Natl Acad Sci U S A. 2014;111(15):E1451–2. https://doi.org/10.1073/pnas.1400195111.

Nakamura Y, Muguruma Y, Yahata T, Miyatake H, Sakai D, Mochida J, et al. Expression of CD90 on keratinocyte stem/progenitor cells. Br J Dermatol. 2006;154(6):1062–70. https://doi.org/10.1111/j.1365-2133.2006.07209.x.

Klein CE, Cordon-Cardo C, Soehnchen R, Cote RJ, Oettgen HF, Eisinger M, et al. Changes in cell surface glycoprotein expression during differentiation of human keratinocytes. J Invest Dermatol. 1987;89(5):500–6. https://doi.org/10.1111/1523-1747.ep12460996.

Groeber F, Holeiter M, Hampel M, Hinderer S, Schenke-Layland K. Skin tissue engineering--in vivo and in vitro applications. Adv Drug Deliv Rev. 2011;63(4-5):352–66. https://doi.org/10.1016/j.addr.2011.01.005.

Bazzoni F, Beutler B. The tumor necrosis factor ligand and receptor families. N Engl J Med. 1996;334(26):1717–25. https://doi.org/10.1056/NEJM199606273342607.

Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004;9(1-3):283–9. https://doi.org/10.2741/1184.

Martin P. Wound healing--aiming for perfect skin regeneration. Science. 1997;276(5309):75–81. https://doi.org/10.1126/science.276.5309.75.

Lebre MC, van der Aar AM, van Baarsen L, van Capel TM, Schuitemaker JH, Kapsenberg ML, et al. Human keratinocytes express functional toll-like receptor 3, 4, 5, and 9. J Invest Dermatol. 2007;127(2):331–41. https://doi.org/10.1038/sj.jid.5700530.

Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585–601. https://doi.org/10.1111/j.1524-475X.2008.00410.x.

Mo IF, Yip KH, Chan WK, Law HK, Lau YL, Chan GC. Prolonged exposure to bacterial toxins downregulated expression of toll-like receptors in mesenchymal stromal cell-derived osteoprogenitors. BMC Cell Biol. 2008;9(1):52. https://doi.org/10.1186/1471-2121-9-52.

Shah JM, Omar E, Pai DR, Sood S. Cellular events and biomarkers of wound healing. Indian J Plast Surg. 2012;45(2):220–8. https://doi.org/10.4103/0970-0358.101282.

Lucas T, Waisman A, Ranjan R, Roes J, Krieg T, Müller W, et al. Differential roles of macrophages in diverse phases of skin repair. J Immunol. 2010;184(7):3964–77. https://doi.org/10.4049/jimmunol.0903356.

Fivenson DP, Faria DT, Nickoloff BJ, Poverini PJ, Kunkel S, Burdick M, Strieter RM. Chemokine and inflammatory cytokine changes during chronic wound healing. Wound Repair Regen. 5:4. https://deepblue.lib.umich.edu/bitstream/handle/2027.42/75761/j.1524-475X.1997.50405.x.pdf?sequence=1.

Moore K, Ruge F, Harding KG. T lymphocytes and the lack of activated macrophages in wound margin biopsies from chronic leg ulcers. Br J Dermatol. 1997;137(2):188–94. https://doi.org/10.1046/j.1365-2133.1997.18041895.x.

Brancato K, Albina JE. Wound macrophages as key regulators of repair: origin, phenotype, and function. Am J Pathol. 2011;178(1):19–25. https://doi.org/10.1016/j.ajpath.2010.08.003.

Zhu J-Q, Wu J, Zhu DX, Scharfman A, Lamblin G, Han KK. Recombinant human granulocyte macrophage colonystimulating factor (rhGM-CSF) induces human macrophage production of transforming growth factor-alpha. Cell Mol Biol. 1991;37(4):413–9.

Brach MA, Sott C, Kiehntopf M, Herrmann F. Expression of the transforming growth factor-alpha gene by human eosinophils is regulated by interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor. Eur J Immunol. 1994;24(3):646–50. https://doi.org/10.1002/eji.1830240324.

Rappolee DA, Mark D, Banda MJ, Werb Z. Wound macrophages express TGF-alpha and other growth factors in vivo: analysis by mRNA phenotyping. Science. 1988;241(4866):708–12. https://doi.org/10.1126/science.3041594.

Cribbs RK, Harding PA, Luquette MH, Besner GE. Endogenous production of heparin-like EGF-like growth factor during murine partial-thickness burn wound healing. J Burn Care Rehabil. 2002;23(2):116–25. https://doi.org/10.1097/00004630-200203000-00008.

Stanley AC, Park HY, Phillips TJ, Russakovsky V, Menzoian JO. Reduced growth of dermal fibroblasts from chronic venous ulcers can be stimulated with growth factors. J Vasc Surg. 1997;26(6):994–9; discussion 999-1001. https://doi.org/10.1016/S0741-5214(97)70012-0.

Mendez MV, Stanley A, Phillips T, Murphy M, Menzoian JO, Park HY. Fibroblasts cultured from distal lower extremities in patients with venous reflux display cellular characteristics of senescence. J Vasc Surg. 1998;28(6):1040–50. https://doi.org/10.1016/S0741-5214(98)70030-8.

Vande Berg JS, Rudolph R, Hollan C, Haywood-Reid PL. Fibroblast senescence in pressure ulcers. Wound Repair Regen. 1998;6(1):38–49. https://doi.org/10.1046/j.1524-475X.1998.60107.x.

Raffetto JD, Mendez MV, Marien BJ, Byers HR, Phillips TJ, Park HY, et al. Changes in cellular motility and cytoskeletal actin in fibroblasts from patients with chronic venous insufficiency and in neonatal fibroblasts in the presence of chronic wound fluid. J Vasc Surg. 2001;33(6):1233–41. https://doi.org/10.1067/mva.2001.113297.

Honnegowda TM, Kumar P, Udupa EGP, Kumar S, Kumar U, Rao P. Role of angiogenesis and angiogenic factors in acute and chronic wound healing. Plast Aesthet Res. 2015;2:243–9.

Thông tin
Thông tin xuất bản

BMC Molecular and Cell Biology

Thông tin tác giả